Gardere Client Rosewood Private Investments Announces Majority Investment in ProTec Laboratory

14 November 2017 News

Gardere client Rosewood Private Investments announced a majority equity investment in ProTec Laboratory, a leading provider of contract manufacturing services to consumer brands in the dietary supplements, sports nutrition, functional foods and pet care products industries.

“By bringing ProTec into the fold, we’ve created a significant platform of scale with enormous potential,” said Paul Richardson, CEO of Rosewood Private Investments’ holding company. “Today, the combined businesses serve well over 100 customers in over 60 markets globally, and we plan to grow far beyond that by focusing on our centers of excellence, as well as through select strategic acquisitions.”

Chris Converse, co-chair of Gardere’s Private Equity Team, and Christopher J. Babcock represented Rosewood Private Investments in the transaction. More information on the deal is available here, and additional background on various Rosewood investments are available via the Dallas Morning News.   

Related Services


What’s Next for Blockchain and Crypto?
01 December 2022
Innovative Technology Insights
Case Law Update: Disputes Relating to Supply Chain Disruptions Hit the Courts
01 December 2022
Manufacturing Industry Advisor
Foley Partner André Thiollier Moderates Global Venture Market Session at BayBrazil Conference
01 December 2022
Foley Ignite
Podcast Episode 96: Eric Williams, Associate
01 December 2022
Foley Career Perspectives
What You Should Know About Payor/Provider Convergence
25-26 January 2023
Los Angeles, CA
ATA EDGE2022 Policy Conference | American Telemedicine Association
7-9 December 2022
Washington, D.C.
CLE Weeks
5-16 December 2022
Milwaukee, WI
Foley Sponsors Ernst & Young Entrepreneur of the Year® Program
1 December 2021 - 30 November 2022
Michigan and Northwest Ohio Region